Table 1.
Patient characteristic | Values | |
Age (years), mean (SD) | 70.3 (8.9) | |
Female, n (%) | 236 (45) | |
Race/ethnicity, n (%) | ||
|
White | 277 (53) |
|
Asian | 118 (23) |
|
Black/African American | 70 (13) |
|
Hispanic | 38 (7) |
|
Other | 20 (4) |
Preferred language, n (%) | ||
|
English | 469 (90) |
|
Chinese | 39 (7) |
|
Spanish | 16 (3) |
Insurance, n (%) | ||
|
Private insurance | 146 (28) |
|
Medicare | 215 (41) |
|
Medicaid | 163 (31) |
Medical co-morbidities, n (%) | ||
|
Cerebrovascular disease | 36 (7) |
|
Congestive heart failure | 40 (8) |
|
Coronary artery disease | 95 (18) |
|
Diabetes mellitus | 199 (38) |
|
Hyperlipidemia | 302 (58) |
|
Hypertension | 377 (72) |
Medication use, n (%) | ||
|
Angiotensin converting enzyme inhibitor/angiotensin II receptor blocker | 319 (61) |
|
Diuretic | 199 (38) |
|
Statin | 353 (67) |
CKD-related outcomes, n (%) | ||
|
Chronic kidney disease (CKD) on problem list | 61 (12) |
|
CKD on problem list or primary care visit diagnosis by ICD-10c codes | 247 (47) |
Systolic BPa (mm Hg), median (Q1-Q3) | 128 (117-140) | |
Diastolic BP (mm Hg), median (Q1-Q3) | 68 (62.5-75) | |
BP controlledb (<140/90), n (%) | 373 (71) | |
Estimated glomerular filtration rate based by serum creatinine (mL/min), mean (SD) | 56.0 (11.8) |
aBP: blood pressure.
bBP control reported based on only the most recent measurement before the start of the study.
cICD-10: International Classification of Diseases, Tenth Revision, Clinical Modification.